PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice

Michael R. McDevitt, Debjit Chattopadhyay, Jaspreet S. Jaggi, Ronald D. Finn, Pat B. Zanzonico, Carlos Villa, Diego Rey, Juana Mendenhall, Carl A. Batt, Jon T. Njardarson, David A. Scheinberg

Research output: Contribution to journalArticle

140 Scopus citations

Abstract

Background. The potential medical applications of nanomaterials are shaping the landscape of the nanobiotechnology field and driving it forward. A key factor in determining the suitability of these nanomaterials must be how they interface with biological systems. Single walled carbon nanotubes (CNT) are being investigated as platforms for the delivery of biological, radiological, and chemical payloads to target tissues. CNT are mechanically robust graphene cylinders comprised of sp2-bonded carbon atoms and possessing highly regular structures with defined periodicity. CNT exhibit unique mechanochemical properties that can be exploited for the development of novel drug delivery platforms. In order to evaluate the potential usefulness of this CNT scaffold, we undertook an imaging study to determine the tissue biodistribution and pharmacokinetics of prototypical DOTA-functionalized CNT labeled with yttríum-86 and indium-111 (86Y-CNT and 111in-CNT, respectively) in a mouse model. Methodology and Principal Findings. The 86Y-CNT construct was synthesized from amine-functionalized, water-soluble CNT by covalently attaching multiple copies of DOTA chelates and then radiolabeling with the positron-emitting metal-ion, yttrium-86. A gamma-emitting 111In-CNT construct was similarly prepared and purified. The constructs were characterized spectroscopically, microscopically, and chromatographically. The whole-body distribution and clearance of yttrium-86 was characterized at 3 and 24 hours post-injection using positron emission tomography (PET). The yttrium-86 cleared the blood within 3 hours and distributed predominantly to the kidneys, liver, spleen and bone. Although the activity that accumulated in the kidney cleared with time, the whole-body clearance was slow. Differential uptake in these target tissues was observed following intraveneous or intraperitoneal injection. Conclusions. The whole-body PET images indicated that the major sites of accumulation of activity resulting from the administration of 86Y-CNT were the kidney, liver, spleen, and to a much less extent the bone. Blood clearance was rapid and could be beneficial in the use of short-lived radionuclides in diagnostic applications.

Original languageEnglish (US)
Article numbere907
JournalPloS one
Volume2
Issue number9
DOIs
StatePublished - Sep 19 2007
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice'. Together they form a unique fingerprint.

  • Cite this

    McDevitt, M. R., Chattopadhyay, D., Jaggi, J. S., Finn, R. D., Zanzonico, P. B., Villa, C., Rey, D., Mendenhall, J., Batt, C. A., Njardarson, J. T., & Scheinberg, D. A. (2007). PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PloS one, 2(9), [e907]. https://doi.org/10.1371/journal.pone.0000907